Skip to main content
PCVX
NASDAQ Life Sciences

Vaxcyte Posts Wider-Than-Expected Q2 Loss of $1.97/Share

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$55.92
Mkt Cap
$8.075B
52W Low
$29.08
52W High
$65
52W Position info
92% above low
Off High info
14% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

PCVX sits 92% above its 52-week low of $29.08.

Summary

Vaxcyte reported a Q2 loss of $1.97 per share, wider than the $1.85 consensus estimate. The miss comes amid heavy R&D spending on its pneumococcal vaccine pipeline, including the Phase 3 VAX-31 program. Cash burn remains elevated, but the company's $500M ATM facility and recent $601.8M follow-on provide runway. No revenue or guidance update was provided. The next catalyst is VAX-31 Phase 3 data expected in 2027.

At the time of this announcement, PCVX was trading at $55.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.1B. The 52-week trading range was $29.08 to $65.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

PCVX - Latest Insights

PCVX
Nov 04, 2026, 5:07 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $65.68
Real-time Price: $55.39 info
Change: -$10.29 (-16%) info
Market Cap: $8.76B info
PCVX
Nov 04, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $65.68
Real-time Price: $55.39 info
Change: -$10.29 (-16%) info
Market Cap: $8.76B info
PCVX
Oct 09, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $71.12
Real-time Price: $55.39 info
Change: -$15.73 (-22%) info
Market Cap: $8.76B info
PCVX
Oct 08, 2026, 4:30 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $64.94
Real-time Price: $55.39 info
Change: -$9.55 (-15%) info
Market Cap: $8.76B info
PCVX
Oct 07, 2026, 6:05 AM EDT
Filing Type: FWP
Importance Score:
8
Price at Filing: $66.40
Real-time Price: $55.39 info
Change: -$11.01 (-17%) info
Market Cap: $8.76B info